Disturbances of electrical activity of the brain induced by the spirolactone derivative potassium canrenoate.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000328:Adult; D000450:Aldosterone / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects*; D001929:Brain Edema / Q000188:drug therapy; D003344:Cortical Synchronization; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy; D013148:Spironolactone / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
D013148:Spironolactone; D000450:Aldosterone